Open Journal of Ophthalmology

Volume 4, Issue 4 (November 2014)

ISSN Print: 2165-7408   ISSN Online: 2165-7416

Google-based Impact Factor: 0.27  Citations  

Atrophy and Fibrosis of Extra-Ocular Muscles in Anti-Acetylcholine Receptor Antibody Myasthenia Gravis

HTML  XML Download Download as PDF (Size: 2691KB)  PP. 117-119  
DOI: 10.4236/ojoph.2014.44019    3,625 Downloads   4,688 Views  Citations

ABSTRACT

Myasthenia gravis (MG) is an autoimmune disorder involving the neuromuscular junction that frequently affects the extra-ocular muscles (EOMs). It has been described as a very rare cause of bilateral EOM atrophy, but histological analysis of such cases is lacking. A 66-year-old man presented with two months of right eyelid drooping and vertical diplopia. Examination showed bilateral ophthalmoparesis and complete right ptosis. The remainder of his exam was normal, and an MRI showed small EOMs. Acetylcholine receptor antibodies were elevated, establishing the diagnosis of MG. Oral corticosteroids and pyridostigmine followed by azathioprine improved his ptosis, but not his ophthalmoparesis. One year later he had surgical correction of his diplopia, and the resected superior rectus muscle showed complete replacement of EOM by connective tissue. MG can rarely cause bilateral EOM atrophy, which is characterized histologically by fibrosis in the muscle itself. Atrophy in the EOMs of a myasthenic patient may indicate a poor response to medical management alone.

Share and Cite:

Gratton, S. , Herro, A. , Bermudez-Magner, J. and Guy, J. (2014) Atrophy and Fibrosis of Extra-Ocular Muscles in Anti-Acetylcholine Receptor Antibody Myasthenia Gravis. Open Journal of Ophthalmology, 4, 117-119. doi: 10.4236/ojoph.2014.44019.

Cited by

[1] Clinical and imaging clues to the diagnosis and follow‐up of ptosis and ophthalmoparesis
Journal of Cachexia …, 2022
[2] Extraocular muscle atrophy in myasthenia gravis
Annals of Indian …, 2022
[3] Radiological Characteristics of Extraocular Muscles in Myasthenia Gravis Patients with Ocular Manifestations: A Case–Control Study
2021
[4] MRI evidence of extraocular muscle atrophy and fatty replacement in myasthenia gravis
2021
[5] Ophthalmologic manifestations in myasthenia gravis: presentation and prognosis
2021
[6] A review of the histopathological findings in myasthenia gravis: Clues to the pathogenesis of treatment-resistance in extraocular muscles
2019
[7] Extraocular Muscle Findings in Myasthenia Gravis Associated Treatment-Resistant Ophthalmoplegia
Journal of Neuro-Ophthalmology, 2017
[8] Endogenic Cytotoxic Factors and Formation of the Clinic Forms of Myasthenia
2016

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.